Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-129990 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 28, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
36,000
Total Value
$303,720.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | Mar 25, 2026 | Exercise/Conversion | 12,000 | $5.20 | $62,400.00 | 124,622 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Mar 25, 2026 | Sale | 12,000 | $20.11 | $241,320.00 | 112,622 | Direct | โ | View Details | |
President, R&D | Stock Option (Right to Buy) | Derivative | Mar 25, 2026 | Exercise/Conversion | 12,000 | $0.00 | $0.00 | 460,500 | Direct | โ | View Details |